Transcriptomics

Dataset Information

0

METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [RNA-Seq 22Rv1 M3 writing]

ABSTRACT: In this study, we used a targeted CRISPR/CasRx-METTL3 screen to identify m6A peaks that are critical for prostate cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE312888 | GEO | 2025/12/15

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Other METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [CRISPR screen_H358]
2025-12-15 | GSE312890 | GEO
Other METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [CRISPR screen_22Rv1]
2025-12-15 | GSE242446 | GEO
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [RNA-Seq 22Rv1 M3 writing]
| PRJNA1377563 | ENA
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers
| PRJNA1013485 | ENA
Transcriptomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers
2025-12-15 | GSE242447 | GEO
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [RNA-Seq_shKD]
| PRJNA1013483 | ENA
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [CRISPR screen_H358]
| PRJNA1377554 | ENA
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [ATAC-Seq]
| PRJNA1076536 | ENA
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [CRISPR screen_22Rv1]
| PRJNA1013491 | ENA
Genomics METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [ChIP-Seq]
| PRJNA1076537 | ENA